background image

Paid Clinical Trials Tulsa

Discover 191 paid clinical trials in Tulsa, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Lenalidomide & Daratumumab

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Tulsa OK, Oklahoma City OK, Fort Smith AR, Joplin MOshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Milvexian

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Tulsa OK, Bartlesville OK, Oklahoma City OK, Springfield MOshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Nivolumab, Ipilimumab, Cabozantinib

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Tulsa OK, Independence KS, Parsons KS, Winfield KSshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

Tralokinumab & Topical Corticosteroids

Recruiting
PHASE3

Sponsor:

LEO Pharma

Location:

Tulsa OK, North Little Rock AR, Birmingham AL, Macon GAshow 14 more

Code:

NCT06311682

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 6 - 11

Healthy Volunteers: Not accepted

Interventions

Tralokinumab + TCS

Placebo + TCS

Sotagliflozin

Recruiting
PHASE3

Sponsor:

Lexicon Pharmaceuticals

Location:

Tulsa OK, Germantown TN, Saint Louis MO, Rochester MNshow 14 more

Code:

NCT06481891

Conditions

Obstructive Cardiomyopathy, Hypertrophic

Non-obstructive Hypertrophic Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sotagliflozin

Placebo

BLU-5937

Recruiting
PHASE3

Sponsor:

Bellus Health Inc. - a GSK company

Location:

Tulsa OK, Oklahoma City OK, Wichita KS, Topeka KSshow 67 more

Code:

NCT05599191

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BLU-5937

Placebo

Sacituzumab Tirumotecan & Pembrolizumab

Recruiting
PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Tulsa OK, Wichita KS, Osage Beach MO, Dallas TXshow 39 more

Code:

NCT06393374

Conditions

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Sacituzumab tirumotecan

Capecitabine

Dexamethasone

Recruiting
PHASE2

Sponsor:

Mercator MedSystems, Inc.

Location:

Bartlesville OK, Denison TX, Houston TX, Houma LAshow 9 more

Code:

NCT04858776

Conditions

Iliofemoral; Thrombosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Perivascular dexamethasone

Perivascular sham

Selinexor

Recruiting
PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Tulsa OK, Oklahoma City OK, Kansas City MO, Little Rock ARshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

Tirzepatide & Ixekizumab

Recruiting

Sponsor:

Eli Lilly and Company

Location:

Tulsa OK, Colleyville TX, Mesquite TX, Irving TXshow 48 more

Code:

NCT06864026

Conditions

Psoriatic Arthritis

Overweight or Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide